PERSONAL CFO SOLUTIONS, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1677501
CHESTER, NJ
Position in TEVA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,094,866
+$146,599 QoQ
Shares Held
32,316
+2.6% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#328
of 671 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PERSONAL CFO SOLUTIONS, LLC holds $2,203,089 across 6 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (49.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
32,316 | $1,094,866 | |
| 2 | TAK |
Takeda Pharmaceutical Co Ltd
|
17,738 | $284,340 | |
| 3 | ZTS |
Zoetis Inc.
|
3,816 | $274,217 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
21,926 | $219,260 | |
| 5 | VTRS |
Viatris Inc
|
11,151 | $177,077 | |
| 6 | HLN |
Haleon plc
|
16,434 | $153,329 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,094,866 | 32,316 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $948,267 | 31,483 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $282,200 | 9,042 | Shares | Defined | 2026-01-22 | |
| 2025-03-31 | $157,680 | 10,259 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $226,835 | 10,292 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $188,849 | 10,480 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||